|Bid||142.42 x 800|
|Ask||143.71 x 800|
|Day's Range||139.60 - 143.80|
|52 Week Range||110.51 - 287.79|
|Beta (3Y Monthly)||2.47|
|PE Ratio (TTM)||77.81|
|Earnings Date||Feb 26, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||231.20|
NEW YORK , Feb. 22, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at Inogen, Inc. ("Inogen" or the "Company") ...
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 8th Annual Leerink Partners Global Healthcare Conference in New York City.
SAN DIEGO , Feb. 12, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP with the assistance of former California Deputy Attorney General and Special Counsel, Tiffany Johnson, Esq. , is ...
Muddy Waters LLC, the renowned research firm run by short seller Carson Block, took aim at medical devices company Inogen Inc. on Friday, saying in a new report that the company's true total addressable market is much smaller than what it has been claiming and accusing management of misleading investors.
Skechers reported 2018 was "a year of record sales," with the fourth quarter breaking above $1 billion in sales for the first time. Goodyear Tire GT — Shares of the tire manufacturer fell nearly 10 percent and hit a new 52-week low Friday after missing Wall Street's expectations for the fourth quarter. Inogen INGN — Inogen's stock slid nearly 7 percent after short-seller Muddy Waters Research said it has taken a short position in the maker of oxygen therapy.
Prominent short seller Carson Block is saying that medical device company Inogen Inc has inflated the size of its markets and expects the stock price to fall. Block, whose research firm Muddy Waters is best known for targeting the shares of China-based companies, has written a new report that asserts that Inogen's management has made overly optimistic growth forecasts. Muddy Waters is short Inogen Inc because it question's Inogen's statements about total addressable market (TAM) size and potential growth, the report seen by Reuters said.
Inogen Inc NASDAQ/NGS:INGNView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is moderate and increasing * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NegativeShort interest is moderately high for INGN with between 10 and 15% of shares outstanding currently on loan. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on January 15. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding INGN totaled $442 million. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release fourth quarter and full year 2018 financial results after market close on Tuesday, February 26, 2019.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Inogen, Inc. (NASDAQ:INGN), which is in the Read More...
NEW YORK, NY / ACCESSWIRE / January 11, 2019 / U.S. markets finished in the green on Thursday, however gains were held back by a sharp decline in Macy’s shares that pressured retail stocks lower. The Dow ...
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 21st Annual Needham Growth Conference in New York City.
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 2019 J.P.
Volatility was the name of the game for stocks in 2018. The market plunged to severe lows in both February and December, but all-time highs in September. The Standard & Poor's 500-stock index and Dow Jones Industrial Average were both on the precipice of bear markets late in the year. However, we enjoyed a surprising "Santa Claus" rally that saw the Dow climb more than 1,000 points - its biggest single-day point gain ever - on Dec. 26. When you're evaluating stock picks for 2019, expect more of the unexpected. Continued volatility seems unavoidable considering unsolved trade tensions and heightened worries about the Federal Reserve and interest-rate hikes. The flip side? "Despite the volatility that we have witnessed in the global markets, for 2019 our analysts are maintaining a pro-growth, pro-cyclical bias," RBC Capital writes in its 2019 outlook. Many Wall Street analysts, in fact, predict upside in 2019. That includes Deutsche Bank, whose 3,250 target for the S&P 500 next year implies more than 30% upside for the market! With this outlook in mind, here are some of the analyst community's top stock picks for 2019. These are stocks, large and small, that boast a "Strong Buy" analyst consensus and significant upside potential. We used TipRanks to ensure that these picks also enjoy the support of top-performing analysts who have strong track records. SEE ALSO: 19 Best Stocks to Buy for 2019 (And 5 to Sell)
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the commercial launch of Inogen Connect.
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed over the past few years. However, hedge funds are generally partially hedged and […]
This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). To keep it practical, we'll show how Inogen Inc's (NASDAQ:INGN) P/E Read More...
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in Nasdaq’s 39th Investor Conference in London.